Inclusion Criteria:  Subject is able to read, understand and sign an IC form 22 or older Self-assessed symptoms are consistent with dry eye (SPEED score ≥ 10) Signs of MGD, as detected in biomicroscopy Fitzpatrick skin type I-V Subject is willing to comply with all study procedures, including return to the clinic 1 day and 1 week after the first and only treatment within the scope of the study  Exclusion Criteria:  • Fitzpatrick skin type VI  Ocular surgery or eyelid surgery, within 3 months prior to screening Recent ocular trauma, within 3 months prior to screening Pre-cancerous lesions, skin cancer or pigmented lesions in the planned treatment area Severe active allergies, or other severe uncontrolled eye disorders affecting the ocular surface Uncontrolled infections or uncontrolled immunosuppressive diseases Subjects with ocular infections requiring the use of antibiotic treatment, within 3 months prior to screening Legally blind in either eye Ocular surface abnormality that may compromise corneal integrity in either eye (e.g., keratoconus, recurrent corneal erosion, corneal epithelial defect, Grade 3 corneal fluorescein staining, map dot fingerprint dystrophy, prior chemical burn) Eyelid abnormalities that affect lid function in either eye, including: entropion, ectropion, tumor, blepharospasm, lagophthalmos, severe trichiasis, and severe ptosis Prior history of cold sores or rashes in the perioral area or in the planned treatment area that could be stimulated by light at a wavelength of 560 nm to 1200 nm, including: Herpes simplex 1 & 2, Systemic Lupus erythematosus, and porphyria Within 3 months prior to screening, use of photosensitive medication and/or herbs that may cause sensitivity to 560-1200 nm light exposure, including: Isotretinoin, Tetracycline, Doxycycline, and St. John's Wort Over exposure to sun, within 4 weeks prior to screening Moderate to severely compromised corneal health as assessed by corneal fluorescein staining Trans-illumination defects Anisocoria or pupil deformation Anterior chamber inflammation Media opacities (cataract, posterior capsule opacification, corneal edema, etc.) that preclude clear visualization of the anterior segment and retina Any condition revealed whereby the investigator deems the subject inappropriate for this study